Cargando…

The Value of Admission Serological Indicators for Predicting 28-Day Mortality in Intensive Care Patients With Acute Heart Failure: Construction and Validation of a Nomogram

Background: Acute heart failure (AHF) is a severe clinical syndrome characterized as rapid onset or worsening of symptoms of chronic heart failure (CHF). Risk stratification for patients with AHF in the intensive care unit (ICU) may help clinicians to predict the 28-day mortality risk in this subpop...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Xiaoyuan, Min, Yu, Yu, Jiangchuan, Wang, Qianli, Wang, Han, Li, Shuang, Su, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678052/
https://www.ncbi.nlm.nih.gov/pubmed/34926602
http://dx.doi.org/10.3389/fcvm.2021.741351
_version_ 1784616268837421056
author Wei, Xiaoyuan
Min, Yu
Yu, Jiangchuan
Wang, Qianli
Wang, Han
Li, Shuang
Su, Li
author_facet Wei, Xiaoyuan
Min, Yu
Yu, Jiangchuan
Wang, Qianli
Wang, Han
Li, Shuang
Su, Li
author_sort Wei, Xiaoyuan
collection PubMed
description Background: Acute heart failure (AHF) is a severe clinical syndrome characterized as rapid onset or worsening of symptoms of chronic heart failure (CHF). Risk stratification for patients with AHF in the intensive care unit (ICU) may help clinicians to predict the 28-day mortality risk in this subpopulation and further raise the quality of care. Methods: We retrospectively reviewed and analyzed the demographic characteristics and serological indicators of patients with AHF in the Medical Information Mart for Intensive Care III (MIMIC III) (version 1.4) between June 2001 and October 2012 and our medical center between January 2019 and April 2021. The chi-squared test and the Fisher's exact test were used for comparison of qualitative variables among the AHF death group and non-death group. The clinical variables were selected by using the least absolute shrinkage and selection operator (LASSO) regression. A clinical nomogram for predicting the 28-day mortality was constructed based on the multivariate Cox proportional hazard regression analysis and further validated by the internal and external cohorts. Results: Age > 65 years [hazard ratio (HR) = 2.47], the high Sequential Organ Failure Assessment (SOFA) score (≥3 and ≤8, HR = 2.21; ≥9 and ≤20, HR = 3.29), lactic acid (Lac) (>2 mmol/l, HR = 1.40), bicarbonate ([Formula: see text]) (>28 mmol/l, HR = 1.59), blood urea nitrogen (BUN) (>21 mg/dl, HR = 1.75), albumin (<3.5 g/dl, HR = 2.02), troponin T (TnT) (>0.04 ng/ml, HR = 4.02), and creatine kinase-MB (CK-MB) (>5 ng/ml, HR = 1.64) were the independent risk factors for predicting 28-day mortality of intensive care patients with AHF (p < 0.05). The novel nomogram was developed and validated with a promising C-index of 0.814 (95% CI: 0.754–0.882), 0.820 (95% CI: 0.721–0.897), and 0.828 (95% CI: 0.743–0.917), respectively. Conclusion: This study provides a new insight in early predicting the risk of 28-day mortality in intensive care patients with AHF. The age, the SOFA score, and serum TnT level are the leading three predictors in evaluating the short-term outcome of intensive care patients with AHF. Based on the nomogram, clinicians could better stratify patients with AHF at high risk and make adequate treatment plans.
format Online
Article
Text
id pubmed-8678052
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86780522021-12-18 The Value of Admission Serological Indicators for Predicting 28-Day Mortality in Intensive Care Patients With Acute Heart Failure: Construction and Validation of a Nomogram Wei, Xiaoyuan Min, Yu Yu, Jiangchuan Wang, Qianli Wang, Han Li, Shuang Su, Li Front Cardiovasc Med Cardiovascular Medicine Background: Acute heart failure (AHF) is a severe clinical syndrome characterized as rapid onset or worsening of symptoms of chronic heart failure (CHF). Risk stratification for patients with AHF in the intensive care unit (ICU) may help clinicians to predict the 28-day mortality risk in this subpopulation and further raise the quality of care. Methods: We retrospectively reviewed and analyzed the demographic characteristics and serological indicators of patients with AHF in the Medical Information Mart for Intensive Care III (MIMIC III) (version 1.4) between June 2001 and October 2012 and our medical center between January 2019 and April 2021. The chi-squared test and the Fisher's exact test were used for comparison of qualitative variables among the AHF death group and non-death group. The clinical variables were selected by using the least absolute shrinkage and selection operator (LASSO) regression. A clinical nomogram for predicting the 28-day mortality was constructed based on the multivariate Cox proportional hazard regression analysis and further validated by the internal and external cohorts. Results: Age > 65 years [hazard ratio (HR) = 2.47], the high Sequential Organ Failure Assessment (SOFA) score (≥3 and ≤8, HR = 2.21; ≥9 and ≤20, HR = 3.29), lactic acid (Lac) (>2 mmol/l, HR = 1.40), bicarbonate ([Formula: see text]) (>28 mmol/l, HR = 1.59), blood urea nitrogen (BUN) (>21 mg/dl, HR = 1.75), albumin (<3.5 g/dl, HR = 2.02), troponin T (TnT) (>0.04 ng/ml, HR = 4.02), and creatine kinase-MB (CK-MB) (>5 ng/ml, HR = 1.64) were the independent risk factors for predicting 28-day mortality of intensive care patients with AHF (p < 0.05). The novel nomogram was developed and validated with a promising C-index of 0.814 (95% CI: 0.754–0.882), 0.820 (95% CI: 0.721–0.897), and 0.828 (95% CI: 0.743–0.917), respectively. Conclusion: This study provides a new insight in early predicting the risk of 28-day mortality in intensive care patients with AHF. The age, the SOFA score, and serum TnT level are the leading three predictors in evaluating the short-term outcome of intensive care patients with AHF. Based on the nomogram, clinicians could better stratify patients with AHF at high risk and make adequate treatment plans. Frontiers Media S.A. 2021-12-03 /pmc/articles/PMC8678052/ /pubmed/34926602 http://dx.doi.org/10.3389/fcvm.2021.741351 Text en Copyright © 2021 Wei, Min, Yu, Wang, Wang, Li and Su. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Wei, Xiaoyuan
Min, Yu
Yu, Jiangchuan
Wang, Qianli
Wang, Han
Li, Shuang
Su, Li
The Value of Admission Serological Indicators for Predicting 28-Day Mortality in Intensive Care Patients With Acute Heart Failure: Construction and Validation of a Nomogram
title The Value of Admission Serological Indicators for Predicting 28-Day Mortality in Intensive Care Patients With Acute Heart Failure: Construction and Validation of a Nomogram
title_full The Value of Admission Serological Indicators for Predicting 28-Day Mortality in Intensive Care Patients With Acute Heart Failure: Construction and Validation of a Nomogram
title_fullStr The Value of Admission Serological Indicators for Predicting 28-Day Mortality in Intensive Care Patients With Acute Heart Failure: Construction and Validation of a Nomogram
title_full_unstemmed The Value of Admission Serological Indicators for Predicting 28-Day Mortality in Intensive Care Patients With Acute Heart Failure: Construction and Validation of a Nomogram
title_short The Value of Admission Serological Indicators for Predicting 28-Day Mortality in Intensive Care Patients With Acute Heart Failure: Construction and Validation of a Nomogram
title_sort value of admission serological indicators for predicting 28-day mortality in intensive care patients with acute heart failure: construction and validation of a nomogram
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678052/
https://www.ncbi.nlm.nih.gov/pubmed/34926602
http://dx.doi.org/10.3389/fcvm.2021.741351
work_keys_str_mv AT weixiaoyuan thevalueofadmissionserologicalindicatorsforpredicting28daymortalityinintensivecarepatientswithacuteheartfailureconstructionandvalidationofanomogram
AT minyu thevalueofadmissionserologicalindicatorsforpredicting28daymortalityinintensivecarepatientswithacuteheartfailureconstructionandvalidationofanomogram
AT yujiangchuan thevalueofadmissionserologicalindicatorsforpredicting28daymortalityinintensivecarepatientswithacuteheartfailureconstructionandvalidationofanomogram
AT wangqianli thevalueofadmissionserologicalindicatorsforpredicting28daymortalityinintensivecarepatientswithacuteheartfailureconstructionandvalidationofanomogram
AT wanghan thevalueofadmissionserologicalindicatorsforpredicting28daymortalityinintensivecarepatientswithacuteheartfailureconstructionandvalidationofanomogram
AT lishuang thevalueofadmissionserologicalindicatorsforpredicting28daymortalityinintensivecarepatientswithacuteheartfailureconstructionandvalidationofanomogram
AT suli thevalueofadmissionserologicalindicatorsforpredicting28daymortalityinintensivecarepatientswithacuteheartfailureconstructionandvalidationofanomogram
AT weixiaoyuan valueofadmissionserologicalindicatorsforpredicting28daymortalityinintensivecarepatientswithacuteheartfailureconstructionandvalidationofanomogram
AT minyu valueofadmissionserologicalindicatorsforpredicting28daymortalityinintensivecarepatientswithacuteheartfailureconstructionandvalidationofanomogram
AT yujiangchuan valueofadmissionserologicalindicatorsforpredicting28daymortalityinintensivecarepatientswithacuteheartfailureconstructionandvalidationofanomogram
AT wangqianli valueofadmissionserologicalindicatorsforpredicting28daymortalityinintensivecarepatientswithacuteheartfailureconstructionandvalidationofanomogram
AT wanghan valueofadmissionserologicalindicatorsforpredicting28daymortalityinintensivecarepatientswithacuteheartfailureconstructionandvalidationofanomogram
AT lishuang valueofadmissionserologicalindicatorsforpredicting28daymortalityinintensivecarepatientswithacuteheartfailureconstructionandvalidationofanomogram
AT suli valueofadmissionserologicalindicatorsforpredicting28daymortalityinintensivecarepatientswithacuteheartfailureconstructionandvalidationofanomogram